Association of bla(VIM-2), bla(PDC-35), bla(OXA-10,) bla(OXA-488) and bla(VEB-9) β-Lactamase Genes with Resistance to Ceftazidime–Avibactam and Ceftolozane–Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa

Ceftazidime–avibactam and ceftolozane–tazobactam are approved for the treatment of complicated Gram-negative bacterial infections including multidrug-resistant (MDR) Pseudomonas aeruginosa. Resistance to both agents has been reported, but the underlying mechanisms have not been fully explored. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Sid Ahmed, Mazen A., Khan, Faisal Ahmad, Hadi, Hamad Abdel, Skariah, Sini, Sultan, Ali A., Salam, Abdul, Al Khal, Abdul Latif, Söderquist, Bo, Ibrahim, Emad Bashir, Omrani, Ali S., Jass, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868128/
https://www.ncbi.nlm.nih.gov/pubmed/35203733
http://dx.doi.org/10.3390/antibiotics11020130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868128/
https://www.ncbi.nlm.nih.gov/pubmed/35203733
http://dx.doi.org/10.3390/antibiotics11020130

Ejemplares similares